Search

everythinglearnresearchcommunity

for

Search:↓

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Children with alopecia areata often have related health issues like allergies, autoimmune diseases, or mental health conditions.

Certain blood cell ratios are higher in kids with alopecia areata and might help predict the disease.

Lower adiponectin and higher leptin levels may predict hair loss in alopecia areata.

Certain hair and scalp features can predict the severity of alopecia areata.

JAK inhibitors may help treat both alopecia areata and vitiligo, but more research is needed.

Patients with Alopecia Areata have higher levels of certain inflammatory markers.

Changes in skin bacteria may relate to alopecia areata severity.

Alopecia areata significantly reduces quality of life.

People with severe and long-lasting alopecia areata often have low vitamin D levels, and treatments with vitamin D-like substances might help.

Baricitinib is a promising treatment for alopecia areata.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Lower survivin levels in blood are linked to more severe and progressing alopecia areata.

Targeting IL-15 may help treat Alopecia Areata.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

High retinol intake may worsen hair loss in alopecia areata.

Patients with Alopecia Areata have lower levels of zinc and biotin than healthy individuals.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

The document suggests using hairpieces, wigs, and safe cosmetic techniques to hide hair loss from alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

COVID-19 infection may trigger alopecia areata in some patients.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.